A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Clinical trial NCT06283966 · RECRUITING

Trial details

NCT number: NCT06283966
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

COPD (Chronic Obstructive Pulmonary Disease)

Start date: 2024-02-21
Primary completion: 2027-12-03
Enrollment: 5250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.